Impact of MRD on progression-free survival in MM patients treated with isatuximab, lenalidomide, bortezomib and dexamethasone

IRANCANSURV: Dissecting the variances in childhood cancer survival across Iran

30 minute infusion of isatuximab shows potential in newly diagnosed multiple myeloma

Understanding cognitive impairment for elderly patients undergoing CAR T therapy

SIOG 2024: Updates in haematology

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study

Isa-VRd shows greater efficacy compared to VRd in transplant-ineligible NDMM patients

Daratumumab-based maintenance regimens show favourable responses in transplant-eligible NDMM

Optimising benefit-risk and minimising impact on quality of life with BCMA-targeting agents in an outpatient setting

Understanding the remaining unmet needs in a post ASCT NDMM setting

Approaches to risk stratification in high risk myeloma

Use of bispecifics and CAR T cells in South America